Inflammatory cells from a tattoo may breach the blood-ocular barrier, which is a wall-like structure designed to protect the ...
A woman in her early 30s had conceived through in vitro fertilization (IVF). Her rising hormone levels confirmed it. But the ...
As IL-6 inhibition comes into practice for PMR, research advances on other therapeutic mechanisms of action, from IL-17 to ...
Objective To present updated integrated safety analyses of bimekizumab in patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA). Methods Safety data pooled from six phase IIb/III ...
UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...